Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

JPMorgan analyst Yang Huang initiated coverage of Ascentage Pharma (AAPG) with an Overweight rating and HK$52 price target The company’s Olverembatinib, having been approved for three CML ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

He worked at a number of leading pharma companies in Hong Kong, including Jacobson Pharma Group and Wai Yuen Tong, before joining Vita Green in 2018, building a breadth of experience within ...

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, ...

BERLIN, March 28, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

For the first time, Thompson shares his journey living with gastroesophageal reflux disease (GERD) and experience using VOQUEZNA, as part of the ...

Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...

The Lodge Bar & Grill at Jacobson Plaza opens April 30th. “Anything from smash burgers, to sandwiches, some shareable options,” The Lodge Wolf said. While, the facility is city-owned ...

leading-edge R&D and radiopharmaceutical manufacturing infrastructure (PRNewsfoto/Actinium Pharmaceuticals, Inc.) Sandesh Seth, Actinium's Chairman and CEO, said, "We are honored to have this ...